Chemical and Pharmaceutical Bulletin p. 3206 - 3213 (1992)
Update date:2022-07-29
Topics:
Tanaka
Ito
Nishino
Motoyama
Takasugi
5-Alkyl-2-aryl-4-pyridylimidazoles were synthesized and tested in rat ex vivo platelet aggregation studies. Among these compounds, 2-(2-fluorophenyl)-5-methyl-4-(3-pyridyl)imidazole (25) was most potent, and showed 98% inhibition at a dose of 10 mg/kg (p.o.). 25 had inhibitory activity on cyclooxygenase, thromboxane A2 (TXA2) synthetase, and phosphodiesterase, and also showed inhibited KCl-induced contraction of rat aorta. All compounds have little acute toxicity and appear to be free of adverse effects on the stomach.
View Morewebsite:http://www.coreychem.com
Contact:+86-371-86658258
Address:Building 10 of Innovation Park, East District of the National University Science Park
Laohekou Jinghong Chemical Co.,Ltd
Contact:+86-0710-3702747
Address:163.East，Huagong Road，Laohekou
Contact:+86-574-89075960
Address:#100 Xiang Yun Road, New High tech area, Ningbo, China
Sino-Biochemical Laboratory Co.,Ltd
Contact:+86 130 4215 5638
Address:Building 33 ,No.123 Shenmei Road , Pudong New District, Shanghai 201318, China
Zhuhai Jiacheng Biological Technology Co., Ltd
Contact:0756-8800233
Address:room 222, Lianhua road , Gongbei ,Zhuhai, Guangdong ,China
Doi:10.1021/ol006737a
(2001)Doi:10.1016/j.tet.2009.06.006
(2009)Doi:10.1007/s00706-013-1120-6
(2014)Doi:10.1002/anie.201913132
(2020)Doi:10.1021/ja01516a039
(1959)Doi:10.1021/cg2002628
(2011)
